((S)-4-Amino-4-carboxybutanoyl)-L-cysteinyl-L-lysine

Catalog No.: 
ACZQEL765
CAS No.: 
128960-73-6
Molecular Formula: 
C14H26N4O6S
Molecular Weight: 
378.45
((S)-4-Amino-4-carboxybutanoyl)-L-cysteinyl-L-lysine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$93.00In stockInquiry
10mg98%$148.00InquiryInquiry
25mg98%$279.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((S)-4-Amino-4-carboxybutanoyl)-L-cysteinyl-L-lysine
IUPAC Name((S)-4-amino-4-carboxybutanoyl)-L-cysteinyl-L-lysine
Molecular FormulaC14H26N4O6S
Molecular Weight378.45
SMILESNCCCC[C@@H](C(O)=O)NC([C@H](CS)NC(CC[C@H](N)C(O)=O)=O)=O
InChI KeyQVQXRPXVRNLLEO-GUBZILKMSA-N
SynonymL--Glutamyl-L-cysteinyl-L-lysine;N2-(N-L--Glutamyl-L-cysteinyl)-L-lysine;L-Lysine, L-γ-glutamyl-L-cysteinyl-;L-gamma-Glutamyl-L-cysteinyl-L-lysine;L-γ-Glutamyl-L-cysteinyl-L-lysine;L-Lysine, L-γ-glutamyl-L-cysteinyl
CAS No.128960-73-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACZQEL765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZQEL765 route product structure diagram
    ACZQEL765128960-73-6In Stock
Inquiry

2. ACZQEL765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZQEL765 route product structure diagram
    ACZQEL765128960-73-6In Stock
Inquiry

3. ACZQEL765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZQEL765 route product structure diagram
    ACZQEL765128960-73-6In Stock
Inquiry

Comments (0)